Damora Therapeutics (DMRA) Preferred Dividend Payments (2019 - 2020)

Damora Therapeutics (DMRA) reported Preferred Dividend Payments of $2.7 million for Q3 2020, up 93.65% on a YoY basis from $1.4 million in Q4 2019, and up 93.65% quarter-over-quarter from $1.4 million in Q4 2019.

Damora Therapeutics (DMRA) Preferred Dividend Payments (2019 - 2020) Analysis & Trends

Damora Therapeutics has reported Preferred Dividend Payments for 2 years, with the latest figure at $2.7 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Damora Therapeutics 731.26 Mn 528.86 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2020 2.71 Mn
Dec 31, 2019 1.40 Mn
Sep 30, 2019 1.40 Mn